These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12468320)

  • 1. Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer?
    Cohn DE; Horowitz NS; Mutch DG; Kim SM; Manolitsas T; Fowler JM
    Gynecol Oncol; 2002 Dec; 87(3):243-6. PubMed ID: 12468320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnitude of risk for nodal metastasis associated with lymphvascular space invasion for endometrial cancer.
    Jorge S; Hou JY; Tergas AI; Burke WM; Huang Y; Hu JC; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Gynecol Oncol; 2016 Mar; 140(3):387-93. PubMed ID: 26768835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphvascular space involvement: an independent prognostic factor in endometrial cancer.
    Briët JM; Hollema H; Reesink N; Aalders JG; Mourits MJ; ten Hoor KA; Pras E; Boezen HM; van der Zee AG; Nijman HW
    Gynecol Oncol; 2005 Mar; 96(3):799-804. PubMed ID: 15721428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer.
    Hahn HS; Lee IH; Kim TJ; Lee KH; Shim JU; Kim JW; Lim KT
    Aust N Z J Obstet Gynaecol; 2013 Jun; 53(3):293-7. PubMed ID: 23600915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between minimally invasive hysterectomy, pelvic cytology, and lymph vascular space invasion: a single institution study of 458 patients.
    Zhang C; Havrilesky LJ; Broadwater G; Di Santo N; Ehrisman JA; Lee PS; Berchuck A; Alvarez Secord A; Bean S; Bentley RC; Valea FA
    Gynecol Oncol; 2014 May; 133(2):211-5. PubMed ID: 24582867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of quantity of lymph-vascular space invasion on the risk of nodal metastases in women with early-stage squamous cancer of the cervix.
    Roman LD; Felix JC; Muderspach LI; Varkey T; Burnett AF; Qian D; Morrow CP
    Gynecol Oncol; 1998 Mar; 68(3):220-5. PubMed ID: 9570969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.
    Bosse T; Peters EE; Creutzberg CL; Jürgenliemk-Schulz IM; Jobsen JJ; Mens JW; Lutgens LC; van der Steen-Banasik EM; Smit VT; Nout RA
    Eur J Cancer; 2015 Sep; 51(13):1742-50. PubMed ID: 26049688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphovascular space involvement is the sole independent predictor of lymph node metastasis in clinical early stage endometrial cancer.
    Vaizoglu F; Yuce K; Salman MC; Basaran D; Calis P; Ozgul N; Usubutun A
    Arch Gynecol Obstet; 2013 Dec; 288(6):1391-7. PubMed ID: 23764931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extent of lymphovascular space invasion and risk of pelvic lymph node metastases in stage IB1 cervical cancer.
    Chandacham A; Charoenkwan K; Siriaunkgul S; Srisomboon J; Suprasert P; Phongnarisorn C; Cheewakraingkrai C; Siriaree S; Tantipalakorn C; Kietpeerakool C
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S31-6. PubMed ID: 17722314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study.
    Stålberg K; Bjurberg M; Borgfeldt C; Carlson J; Dahm-Kähler P; Flöter-Rådestad A; Hellman K; Hjerpe E; Holmberg E; Kjølhede P; Marcickiewicz J; Rosenberg P; Tholander B; Åvall-Lundqvist E; Högberg T
    Acta Oncol; 2019 Nov; 58(11):1628-1633. PubMed ID: 31373248
    [No Abstract]   [Full Text] [Related]  

  • 12. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.
    Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S
    Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LVSI positive and NX in early endometrial cancer: Surgical restaging (and no further treatment if N0), or adjuvant ERT?
    Harris KL; Maurer KA; Jarboe E; Werner TL; Gaffney D
    Gynecol Oncol; 2020 Jan; 156(1):243-250. PubMed ID: 31703813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of recurrence in stage I endometrioid endometrial adenocarcinoma with lymphovascular space invasion.
    Simpkins F; Papadia A; Kunos C; Michener C; Frasure H; AbuShahin F; Mariani A; Bakkum-Gamez JN; Landrum L; Moore K; Thomas SG; Windhorn A; Rose PG
    Int J Gynecol Cancer; 2013 Jan; 23(1):98-104. PubMed ID: 23221731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological risk factors for pelvic lymph node metastasis in clinical early-stage endometrioid endometrial adenocarcinoma.
    Zhang C; Wang C; Feng W
    Int J Gynecol Cancer; 2012 Oct; 22(8):1373-7. PubMed ID: 22932266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy.
    Ho CM; Chien TY; Huang SH; Wu CJ; Shih BY; Chang SC
    Gynecol Oncol; 2004 May; 93(2):458-64. PubMed ID: 15099962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram with potential clinical use to predict lymph node metastasis in endometrial cancer patients diagnosed incidentally by postoperative pathological assessment.
    Taşkın S; Şükür YE; Varlı B; Koyuncu K; Seval MM; Ateş C; Yüksel S; Güngör M; Ortaç F
    Arch Gynecol Obstet; 2017 Oct; 296(4):803-809. PubMed ID: 28762064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors of pelvic lymph node metastasis in cervical adenocarcinoma following radical hysterectomy and pelvic lymphadenectomy.
    Yanaranop M; Sathapornteera N; Nakrangsee S
    J Med Assoc Thai; 2014 Nov; 97 Suppl 11():S87-95. PubMed ID: 25509701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
    Ivanov I
    Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis.
    Holloway RW; Gupta S; Stavitzski NM; Zhu X; Takimoto EL; Gubbi A; Bigsby GE; Brudie LA; Kendrick JE; Ahmad S
    Gynecol Oncol; 2016 May; 141(2):206-210. PubMed ID: 26905211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.